Home  |   Companies  |   Targets  |   Drugs  |   Diseases  |   Search  |   Help  |   About Blog Blog | Twitter Twitter | Rss SciBite News | Contact Contact   
LogoBeta Software
Open Drug Discovery Intelligence
     
searchSearch Scibite.com

Targets, Diseases & Drug Names All News
a- A+
SCIBITE NEWS:

Adipose Derived Stem Cells Protect Skin Flaps Against Ischemia-Reperfusion Injury
Thu Apr 26 01:52:45 BST 2012
Key Topics

Click on any of the topic names to view its own newsletter. The text we matched to the topic is shown in grey underneath.

 Reperfusion Injury

[matched:ischemia reperfusion injury]

Other Topics Mentioned

Less relevant than those above but listed here for convenience.


 Ischemia

[matched:ischemia]

 Inflammation

[matched:inflammatory]

Altmetric Article Ranking
Altmetric is a new way of monitoring impact of journal articles across social media, provided by altmetric.com. Click on the badge to see more information about this article from Altmetric.

   
: Advances in the treatment of ischemia- reperfusion injury have created an opportunity for plastic surgeons to apply these treatments to flaps and implanted tissues. We examined the capability of adipose derived stem cells (ADSCs) to protect tissue against IRI using an extended inferior epigastric artery skin flap as a flap ischemia- reperfusion injury (IRI) model. METHODS: ADSCs were isolated from Lewis rats and cultured in vitro. Twenty- four rats were randomly divided into three groups. Group I was the sham group and did not undergo ischemic insult; rather, the flap was raised and immediately sutured back (non-ischemic control group). Group II (ischemia control) and group III (ADSCs treatment) underwent 3 h of ischemic insult. During reperfusion group III was treated by intravenous application of ADSCs and group II was left untreated. Five days postoperatively, flap survival and perfusion were assessed. Microvessel density was visualized by immunohistochemistry and semi- quantitative real-time polymerase chain reaction addressed differential gene expression. RESULTS: Treatment with ADSCs significantly increased flap survival (p < 0.001) and flap perfusion (p < 0.001) when compared to the control group II. Microvessel- density in ADSCs treated group was not significantly increased in any group. No significant differences showed the comparison of the experimental group III and the sham operated control group I. ADSCs treatment (Group III) was accompanied by a significantly enhanced expression of pro-angiogenic and pro-inflammatory genes. CONCLUSION: Overall, our study demonstrates that ADSCs treatment significantly enhances skin flap survival in the aftermath of ischemia to an extent that almost equals surgical results without ischemia. This effect is accompanied with a pronounced and significant angiogenic response and an improved blood perfusion;   Read more on this story here

Source: ncbi.nlm.nih.gov   (view original)
Inst: ETHIANUM - Clinic for Plastic and Reconstructive Surgery, Aesthetic and Preventive Medicine at Heidelberg University Hospital, Vossstr. 6, 69115, Heidelberg, Germany, [email protected]
   abstracted provided by MEDLINE/PubMed, a database of the U.S. National Library of Medicine.

Summary Loaded